A study in people with type 1 diabetes to determine how well a meal-time insulin, LY900014, controls diabetes compared to Humalog (insulin lispro) when both are used along with a long-acting insulin.
- Conditions
- Type 1 DiabetesMedDRA version: 20.1Level: LLTClassification code 10020639Term: HyperglycemiaSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Registration Number
- EUCTR2015-005356-99-SE
- Lead Sponsor
- Eli Lilly and Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 1392
• You were diagnosed with type 1 diabetes at least one year ago.
• You are 18 years old or older.
• You are already using a long-acting insulin and rapid-acting insulin analog.
• Your blood glucose levels are within allowed limits for study participation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1175
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 392
• You have had more than 1 emergency treatment for very low blood glucose in the last 6 months.
• You have had more than 1 emergency treatment for poor glucose control in the last 6 months.
• You are taking certain diabetes medications that are not allowed for study participation.
• You have major problems with your heart, kidneys, liver, or you have a blood disorder.
• You have had or are now being treated for certain types of cancer that prevents you from study participation.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method